About Stable Pharma
Stable Pharma is a company based in Bath (United Kingdom) founded in 2011. Stable Pharma has raised $4.28 million across 4 funding rounds from investors including European Union, Ascension and EIC Fund. The company has 1 employees as of January 31, 2020. Stable Pharma offers products and services including StablevaX™ and SPVX02. Stable Pharma operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Bath, United Kingdom
- Employees 1 as on 31 Jan, 2020
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Stablepharma Limited
- Date of Incorporation 26 Jan, 2012
- Jurisdiction BRISTOL, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.28 M (USD)
in 4 rounds
-
Latest Funding Round
$2.76 M (USD), Series A
Sep 17, 2021
-
Investors
European Union
& 2 more
-
Employee Count
1
as on Jan 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stable Pharma
Stable Pharma offers a comprehensive portfolio of products and services, including StablevaX™ and SPVX02.
Technology that thermally stabilizes vaccines without refrigeration needs
Fridge-free vaccine for preventing Tetanus and Diphtheria
People of Stable Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of Stable Pharma
Stable Pharma has successfully raised a total of $4.28M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $2.76 million completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Stable Pharma
Stable Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Ascension and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ascension is recognized as a venture capital firm focused on early-stage tech investments.
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Stable Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stable Pharma
Investment portfolio details for Stable Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Stable Pharma
Detailed financials for Stable Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stable Pharma Comparisons
Peer comparison for Stable Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stable Pharma
Stable Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Stable Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stable Pharma
Complete news archive for Stable Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stable Pharma
Stable Pharma was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Stable Pharma is headquartered in Bath, United Kingdom. It is registered at Bath, Somerset, United Kingdom.
Stable Pharma is a funded company, having raised a total of $4.28M across 4 funding rounds to date.
As of Jan 31, 2020, the latest employee count at Stable Pharma is 1.
Stable Pharma was founded in 2011 in Bath, United Kingdom, within the pharmaceutical technology sector. Technology is provided by the company to enable stable storage and delivery of drugs and vaccines. Precise dosages are pre-loaded into syringes during manufacturing, which minimizes wastage and ensures accurate administration to patients. Stability of the formulations is maintained without temperature sensitivity, eliminating refrigeration requirements during transport and storage.
Stable Pharma's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Stable Pharma offers StablevaX™ and SPVX02.
Stable Pharma has 3 investors. Key investors include European Union, Ascension, and EIC Fund.